Patients aged @ years or older with American Joint Committee on Cancer stage ( AJCC ) stage IIB , IIC , and III cutaneous melanoma were randomly allocated ( @:@ ) , via a central , computer-based minimisation procedure , to receive intravenous bevacizumab @ mg/kg , every @ weeks for @ year , or to observation .